Volume 68, Issue 4, Pages (October 2005)

Slides:



Advertisements
Similar presentations
Increased cGMP phosphodiesterase activity mediates renal resistance to ANP in rats with bile duct ligation  Xi-Ping Ni, Massy Safai, David G. Gardner,
Advertisements

The roles of IGF-I and IGFBP-3 in the regulation of proximal tubule, and renal cell carcinoma cell proliferation  Catherine W. Cheung, David A. Vesey,
Volume 84, Issue 3, Pages (September 2013)
Volume 58, Issue 1, Pages (July 2000)
Renal vitamin D receptor expression and vitamin D renoprotection
Peter A. McCullough, MD, MPH, Timothy Larsen, DO, Jeremiah R
Volume 78, Issue 2, Pages (July 2010)
Inhibition of proximal convoluted tubule transport by dopamine
Section 5: Dialysis Interventions for Treatment of AKI
Volume 68, Issue 3, Pages (September 2005)
Volume 64, Issue 6, Pages (December 2003)
Vitamin E attenuates crystal formation in rat kidneys: Roles of renal tubular cell death and crystallization inhibitors  H.-S. Huang, J. Chen, C.-F. Chen,
Volume 59, Issue 5, Pages (May 2001)
Hiroyuki Kobori, Lisa M. Harrison-Bernard, L. Gabriel Navar 
Volume 71, Issue 8, Pages (April 2007)
Volume 60, Issue 4, Pages (October 2001)
Volume 71, Issue 5, Pages (March 2007)
Volume 68, Issue 4, Pages (October 2005)
Effects of antihypertensive therapy on intrarenal angiotensin and bradykinin levels in experimental renal insufficiency  Fiona E. Mackie, Timothy W. Meyer,
Volume 55, Issue 1, Pages (January 1999)
Proinflammatory effects of iron sucrose in chronic kidney disease
Comparative effects of potassium chloride and bicarbonate on thiazide-induced reduction in urinary calcium excretion  Lynda A. Frassetto, Eileen Nash,
Volume 72, Issue 3, Pages (August 2007)
The roles of IGF-I and IGFBP-3 in the regulation of proximal tubule, and renal cell carcinoma cell proliferation  Catherine W. Cheung, David A. Vesey,
Volume 87, Issue 2, Pages (February 2015)
Impaired response of the denervated kidney to endothelin receptor blockade in normotensive and spontaneously hypertensive rats  Radoslav Girchev, Angela.
Volume 61, Issue 6, Pages (June 2002)
Volume 71, Issue 6, Pages (March 2007)
Volume 72, Issue 5, Pages (September 2007)
Volume 68, Issue 2, Pages (August 2005)
Volume 53, Issue 6, Pages (June 1998)
Transient neonatal cystinuria
Colonic H+-K+-ATPase is induced and mediates increased HCO3− reabsorption in inner medullary collecting duct in potassium depletion  Suguru Nakamura,
Volume 72, Issue 12, Pages (December 2007)
Volume 87, Issue 1, Pages (January 2015)
Reduced adenosine A2a receptor–mediated efferent arteriolar vasodilation contributes to diabetes-induced glomerular hyperfiltration  Patrik Persson, Peter.
Volume 68, Issue 2, Pages (August 2005)
Cyclosporine A attenuates the natriuretic action of loop diuretics by inhibition of renal COX-2 expression  Klaus Höcherl, Frieder Kees, Bernhard K. Krämer,
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
STAT proteins mediate angiotensin II–induced production of TIMP-1 in human proximal tubular epithelial cells  Xiangmei Chen, Jianzhong Wang, Feng Zhou,
Role of the T-cell receptor in kidney ischemia–reperfusion injury
Robert L. Chevalier, Barbara A. Thornhill, Alice Y. Chang 
Increased cGMP phosphodiesterase activity mediates renal resistance to ANP in rats with bile duct ligation  Xi-Ping Ni, Massy Safai, David G. Gardner,
Volume 58, Issue 3, Pages (September 2000)
Ho Jae Han, Soo Hyun Park, Hyun Ju Koh, Mary Taub  Kidney International 
Insulin resistance and hypertension: new insights
H+-ATPase activity on unilateral ureteral obstruction: Interaction of endogenous nitric oxide and angiotensin II  Patricia G. Valles, Walter A. Manucha 
Protective effect of 20-hydroxyeicosatetraenoic acid (20-HETE) on glomerular protein permeability barrier  Ellen T. Mccarthy, R.A.M. Sharma, Mukut Sharma,
Lu-Cheng Cao, Thomas Honeyman, Julie Jonassen, Cheryl Scheid 
Volume 64, Issue 3, Pages (September 2003)
Volume 57, Issue 2, Pages (October 2000)
Ganesan Ramesh, W. Brian Reeves  Kidney International 
Silvia B. Campos, Lucia H.K. Rouch, Antonio C. Seguro 
Volume 63, Issue 1, Pages (January 2003)
Latest findings in phosphate homeostasis
Volume 62, Issue 4, Pages (October 2002)
David Z. Levine, M.D., Michelle Iacovitti, Kevin D. Burns, Amy Slater 
Volume 68, Issue 5, Pages (November 2005)
Volume 55, Issue 3, Pages (March 1999)
Is complement a target for therapy in renal disease?
Volume 62, Issue 5, (November 2002)
Erratum Kidney International Volume 61, Issue 4, (April 2002)
Estrogen downregulates the proximal tubule type IIa sodium phosphate cotransporter causing phosphate wasting and hypophosphatemia  S. Faroqui, M. Levi,
Volume 55, Issue 5, Pages (May 1999)
Volume 60, Issue 3, Pages (September 2001)
Volume 62, Issue 3, Pages (September 2002)
Quantitative estimation of renal blood flow by power Doppler ultrasonography in renovascular hypertensive dogs  Tetsumasa Miyajima, Hiroshi Yokoyama,
Marie Leclerc, Michèle G. Brunette, Denis Couchourel 
Plasma concentration and urinary excretion of N-terminal proatrial natriuretic peptides in patients with kidney diseases  Martina Franz, Wolfgang Woloszczuk,
Presentation transcript:

Volume 68, Issue 4, Pages 1700-1707 (October 2005) Prolactin, a natriuretic hormone, interacting with the renal dopamine system  Fernando Ibarra, Susanne Crambert, Ann-Christine Eklöf, Annika Lundquist, Peter Hansell, Ulla Holtbäck  Kidney International  Volume 68, Issue 4, Pages 1700-1707 (October 2005) DOI: 10.1111/j.1523-1755.2005.00586.x Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 1 Immunoreactivity of renal localization of prolactin receptors (PRLR) in renal tissue. A representative blot of PRLR in pituitary gland (PG), renal cortex (RC), and microdissected renal proximal convoluted tubular (PTC) segments. Kidney International 2005 68, 1700-1707DOI: (10.1111/j.1523-1755.2005.00586.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 2 Effect of prolactin on renal proximal convoluted tubular (PCT) Na+, K+-ATPase activity. (A) Time dependence. Prolactin was used in a concentration of 1 μg/mL. Values are mean ± SEM and are expressed as pmol Pi/mm tubule/hour (N = 3 to 5 per group). *P < 0.05 vs. control; **P < 0.05 vs. control and < 0.05 vs. prolactin 15 minutes. Statistical analysis was performed with unpaired Student t test. (B) Dose dependence. Proximal tubules were incubated with prolactin for 15 minutes. Values are mean ± SEM and are expressed as pmol Pi/mm tubule/hour (N = 3 to 5 per group). *P < 0.05 vs. control. Statistical analysis was performed with unpaired Student t test. ns is not significant vs. control. Kidney International 2005 68, 1700-1707DOI: (10.1111/j.1523-1755.2005.00586.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 3 Interaction between prolactin and intrarenal dopamine. Proximal tubules were incubated with prolactin, 1 μg/mL, for 15 minutes. Values are mean ± SEM and are expressed as pmol Pi/mm tubule/hour. Statistical analysis was performed with paired and unpaired Student t test. (A) Dopamine antagonists. Proximal tubules preincubated with SCH23390, 10-6 mol/L, or raclopride, 10-6 mol/L (N = 4 to 6 per group). *P < 0.05 vs. control. ns is not significant vs. control. (B) Aromatic amino acid decarboxylase (AADC) inhibitors. Proximal tubules preincubated with benserazide 10-5 mol/L or carbidopa 5 × 10-4 mol/L (N = 8 in the benserazide group and three in the carbidopa group). ns is not significant vs. benserazide alone; NS is not significant vs. carbidopa alone. Kidney International 2005 68, 1700-1707DOI: (10.1111/j.1523-1755.2005.00586.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 4 Effects of prolactin on renal function. C1 and C2 correspond to collection periods 1 and 2 before and E1 to E4 correspond to collection periods 1 to 4 periods after treatment with vehicle, prolactin, and prolactin and SCH23390 (N = 6 to 7 per group). *P < 0.05 vs. control. Statistical analysis was performed with paired and unpaired Student t test. (A) Urinary sodium excretion. Values are mean ± SEM and are expressed as μmol/min/g kidney weight. (B) Urinary flow. Values are means ± SEM and are expressed as μL/min/g kidney weight. (C) Urinary potassium excretion. Values are mean ± SEM and are expressed as μmol/min/g kidney weight. Kidney International 2005 68, 1700-1707DOI: (10.1111/j.1523-1755.2005.00586.x) Copyright © 2005 International Society of Nephrology Terms and Conditions